Noesis Pharma Clinical Trials

Executive Summary

Noesis Pharma Clinical Trials is a dedicated clinical research center based in Phoenix, Arizona, specializing in the execution of Phase II–IV clinical trials, with a primary focus on central nervous system (CNS) disorders such as Major Depressive Disorder and Obsessive-Compulsive Disorder. Founded in 2015, the company operates as a site management organization, offering patient recruitment, trial execution, and data collection services to pharmaceutical and biotechnology sponsors. By concentrating on CNS indications, Noesis Pharma addresses a significant therapeutic area with high unmet need, positioning itself as a specialized partner for sponsors seeking efficient trial conduct and patient access in the southwestern United States. As a private, U.S.-based site management organization, Noesis Pharma plays a critical role in the clinical development ecosystem, facilitating the timely execution of late-stage trials. While the company does not develop its own therapies, its expertise in CNS trial management and patient enrollment supports the advancement of novel treatments. The company's value lies in its operational capabilities and localized patient populations, which can accelerate study timelines. However, as a service provider, its growth is tied to sponsor demand and trial awards. With the increasing focus on CNS disorders, Noesis Pharma is well-positioned to benefit from ongoing R&D investments in this area, though its impact on specific drug approvals remains indirect.

Upcoming Catalysts (preview)

• Q3 2026Award of new CNS trial contracts from pharmaceutical sponsors60% success